2020 Pipeline Guide: Proto Oncogene Tyrosine Protein Kinase ROS – Therapeutics Development & Assessment, Companies Involved, Drug Profiles, Dormant Projects, Discontinued Products
- Monday, March 30, 2020, 7:01
- Finance
- Add a comment
DUBLIN, March 30, 2020 /PRNewswire/ — The “Proto Oncogene Tyrosine Protein Kinase ROS – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Proto Oncogene Tyrosine Protein Kinase ROS pipeline target constitutes close to 9 molecules. Out of which…
About the Author
adminasapcorp has written 41279 stories on this site.